Alzheimer's Disease patients may have a new friend in the medicine game, as the first skin patch meant to treat dementia has just received FDA approval as of early this week.

The 'Exelon' patch provides the same drug that current capsules provide but provides a regular and consistent dose through the skin throughout the day. The patch, like the capsule, will be made by Novartis pharmaceuticals.

Although the drug is not a cure, it does stop the breakdown of a brain chemical that is affected by dementia once the onset of Alzheimer's Disease begins.